ACAD
49.3
+1.74
+3.66%
AEMD
9.58
-0.42
-4.20%
APRI
1.47
-0.05
-3.29%
ARNA
4.08
+0.09
+2.26%
ATEC
1.36
-0.01
-0.73%
CNAT
5.02
+0.12
+2.45%
CRXM
0.3
+0.01
+1.73%
CYTX
0.44
+0.04
+9.97%
DXCM
83.41
+1.71
+2.09%
GNMK
8.83
-0.27
-2.97%
HALO
23.71
+0.91
+3.99%
ILMN
217.82
+0.55
+0.25%
INNV
0.155
-0.003
-1.899%
INO
7.4
+0.22
+3.06%
ISCO
0.043
-0.005
-10.5263%
ISIS
54.4
+0.72
+1.34%
LGND
105.84
+3.29
+3.21%
LPTN
0.28
0.00
0.00%
MBVX
1.59
-0.01
-0.62%
MEIP
1.57
+0.02
+1.29%
MNOV
3.65
-0.16
-4.20%
MRTX
29.3
+1.06
+3.75%
MSTX
0.46
-0.01
-1.63%
NBIX
51.92
+2.58
+5.23%
NUVA
50.47
+0.88
+1.77%
ONCS
6.27
+0.24
+3.98%
ONVO
3.37
-0.01
-0.30%
OREX
4.39
+0.18
+4.28%
OTIC
27.28
+0.3
+1.11%
QDEL
21.88
-0.51
-2.28%
RCPT
227.16
+0.07
+0.03%
RGLS
8.92
+0.24
+2.76%
RMD
56.7
+1.53
+2.77%
SCIE
0.02
0.00
+5.26%
SPHS
0.91
+0.05
+5.8488%
SRNE
20.41
-3.29
-13.88%
TROV
8.35
-0.17
-2.00%
VICL
0.64
+0.03
+4.92%
ZGNX
20.14
+0.27
+1.36%
ACAD
49.3
+1.74
+3.66%
AEMD
9.58
-0.42
-4.20%
APRI
1.47
-0.05
-3.29%
ARNA
4.08
+0.09
+2.26%
ATEC
1.36
-0.01
-0.73%
CNAT
5.02
+0.12
+2.45%
CRXM
0.3
+0.01
+1.73%
CYTX
0.44
+0.04
+9.97%
DXCM
83.41
+1.71
+2.09%
GNMK
8.83
-0.27
-2.97%
HALO
23.71
+0.91
+3.99%
ILMN
217.82
+0.55
+0.25%
INNV
0.155
-0.003
-1.899%
INO
7.4
+0.22
+3.06%
ISCO
0.043
-0.005
-10.5263%
ISIS
54.4
+0.72
+1.34%
LGND
105.84
+3.29
+3.21%
LPTN
0.28
0.00
0.00%
MBVX
1.59
-0.01
-0.62%
MEIP
1.57
+0.02
+1.29%
MNOV
3.65
-0.16
-4.20%
MRTX
29.3
+1.06
+3.75%
MSTX
0.46
-0.01
-1.63%
NBIX
51.92
+2.58
+5.23%
NUVA
50.47
+0.88
+1.77%
ONCS
6.27
+0.24
+3.98%
ONVO
3.37
-0.01
-0.30%
OREX
4.39
+0.18
+4.28%
OTIC
27.28
+0.3
+1.11%
QDEL
21.88
-0.51
-2.28%
RCPT
227.16
+0.07
+0.03%
RGLS
8.92
+0.24
+2.76%
RMD
56.7
+1.53
+2.77%
SCIE
0.02
0.00
+5.26%
SPHS
0.91
+0.05
+5.8488%
SRNE
20.41
-3.29
-13.88%
TROV
8.35
-0.17
-2.00%
VICL
0.64
+0.03
+4.92%
ZGNX
20.14
+0.27
+1.36%
Home » Events

SDBN October 26th Event Featuring Trius Therapeutics

Submitted by on October 19, 2010 – 2:57 pm

Dr. John Finn, Trius Therapeutics’ Chief Scientific Officer, will present a talk titled “Innovative Antibacterial Drugs by Design; The Trius Therapeutics Story.”

Date/Time Start:: Oct. 26 5:30 p.m.

Date/Time End:: Oct. 26th 9:00 p.m.

Cost to Attend: ( Academic)

Web Address:: http://sdbn.org/october

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


one × 5 =